Spencer Strider’s rise was fast enough to make him feel like a fixture before he’d even settled in. In 2022, he finished second in NL Rookie of the Year voting behind teammate Michael Harris II after piling up 202 strikeouts in 131 2/3 innings, allowing only seven homers and posting a 2.67 ERA, a 1.83 FIP and 4.9 WAR. He backed that up the next year by making the NL All-Star team and drawing votes on more than two-thirds of the Cy Young ballots.
Then the injuries started stacking up.
Two starts into 2024, Strider’s velocity had already dipped and he was dealing with elbow pain, which ended his season early and sent him to an internal brace procedure. Since then, he hasn’t looked like the same pitcher.
Now he’s out again with another elbow issue, and MLB.com’s Mark Bowman has added weight to the chatter that Strider may not return in 2026 as a starter. That’s the same buzz I’ve heard too, though Bowman’s Braves connections are obviously stronger than mine.
The bigger question is what comes next. If Strider’s 2026 is shortened by injury, what kind of pitcher is he in projection terms? And if the Braves eventually decide his best path is the bullpen, what would that look like?
Not every inning lost this season has been about the elbow. An oblique injury pushed back his debut until May.
But once he returned, the old version still wasn’t there. He can still miss bats, but not at the rate he did in 2022, when he was at his peak.
His fastball has settled at an average of 95.1 mph, down from that earlier power. The walks have climbed to 4.6 per nine innings, and that has driven his FIP to 5.36, almost the same as his 5.31 ERA.
Statcast’s xERA, at 3.49, offered a friendlier read.
His eighth start of the year, against the New York Mets, showed the shape of the problem. He opened by firing 96-mph fastballs to Carson Benge and Bo Bichette, but the heat faded as the outing wore on.
By the third inning, he was working below 90. His final pitch to MJ Melendez came in at 87.8 mph, which is only a fastball if you’re Tyler Rogers.
The Braves pulled him, and he was shut down for four weeks.
Since then, there hasn’t been much public word on Strider. With the injury history piling up and the calendar moving on, it’s getting tougher to imagine him simply sliding back into the rotation for five-inning starts.
I reran his 2027 projections and beyond assuming he does not return this season, and the picture that comes back is useful but far from the star-level ceiling he once carried. ZiPS sees a league-average starter, the kind of pitcher you might trust for 160 innings if you can actually get them - but not the force Strider used to be.
Even the comp list has changed. Where his top ZiPS matches entering 2022 included Don Drysdale, Dizzy Dean and Erik Hanson, the newer group is a lot less glamorous: Kevin Foster, Melido Perez and Tim Belcher.
That’s why the bullpen talk keeps hanging around. Strider’s MRI showed inflammation rather than structural damage, but this is his second major elbow operation.
At Clemson, he missed the 2019 season after full Tommy John surgery. Jacob deGrom is the obvious reason not to close the book on a starter’s future after arm trouble, but deGrom was still excellent whenever he was healthy from 2021 to 2024.
Strider, by comparison, has been more “meh” when available. And unlike deGrom, whose fastball trim has been deliberate in service of staying healthy, Strider’s lost velocity doesn’t seem to be a choice.
That drop is also part of why a relief role makes sense. The issue isn’t just that the velocity is down; it’s that it fades so early in his starts.
If he only has to cover one or two innings, he can go after hitters immediately and avoid the late-start decline altogether. He already has the shape of a reliever’s mix, too.
At his peak, he was basically a fastball-slider arm, and even now his curveball and changeup mostly exist to keep lefties honest. That means he wouldn’t need a major overhaul to fit shorter outings.
His poor first-inning numbers as a starter are worth noting, but they aren’t a reliable predictor when a pitcher changes roles.
ZiPS has plenty of starter-to-bullpen and bullpen-to-starter data, and it thinks Strider could handle relief well.
Whether that’s as valuable as a healthy No. 2 or No. 3 starter is up for debate. But if it helps keep him on the field, it’s hard to argue against.
The Braves have done this before with John Smoltz, who battled elbow pain in 1998 and 1999 before missing 2000 after Tommy John surgery. He then gave Atlanta four strong years in the bullpen before returning to the rotation in 2005 and pitching like an ace for three more seasons.
The Braves would love the 2022-2023 version of Strider back at the top of the rotation with Chris Sale. But what they may actually need is simply to get Strider back on the mound, period. If that means shorter, higher-leverage outings and less time on the injured list - and less time in the surgeon’s chair - it may be the best compromise they can make.
In Other News...
Braves Just Cleared Two Roster Spots For A Bigger Deadline Shift
The Braves used the deadline to shuffle the margins of their roster, dealing catcher Joey Bart to the White Sox and sending outfielder Eli White to the Red Sox in separate moves. In return, Atlanta picked up right-hander Duncan Davitt and minor league reliever Tyler Uberstine, with the latter optioned to Triple-A Gwinnett, a sign these were as much about clearing space as adding immediate help.
Those openings matter because the roster is not done changing. Atlanta has a potential return behind the plate looming in Sean Murphy, and another outfield addition in Lane Thomas could soon fit into the mix as well, giving the club a little more flexibility for the stretch run. For a team trying to line up the right pieces after deadline day, the next round of moves may end up being the more interesting part of this one. [Read more 🡒]
Braves Catching Picture Is Finally Changing At The Right Time
Joey Barts brief run as Atlantas backup catcher has come to an end after the Braves and White Sox struck a trade that sends him to Chicago for rookie right-hander Duncan Davitt. Bart had been filling in behind the plate for Atlanta, but the clubs catching picture is now shifting with the roster moving toward a different look.
Davitt arrives with a little bit of big league experience already, having made two major league appearances with Chicago before the deal. For the Braves, the rookie is expected to work out of the bullpen, giving them another arm as they reshape the back end of the staff and prepare for the next step in the catching rotation. [Read more 🡒]
Braves Take Another Rotation Gamble With Tyler Mahle
The Braves dipped back into the rotation market with another move aimed at stabilizing the back end of their staff, acquiring right-hander Tyler Mahle from the Giants for right-hander Anthony Molina. Mahle has logged 18 starts this season in San Francisco, and while the results have been uneven, Atlanta is clearly banking on a change of scenery and a different voice to get more out of him down the stretch.
Jeremy Hefner now gets the challenge of helping Mahle sharpen things up in Atlanta, where the Braves have made it a priority to keep searching for usable innings. Molina had only thrown five innings for the club in 2026, so this is the kind of deal that says the Braves are willing to keep tinkering if they think there is still a path to more reliable starting help. [Read more 🡒]